A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Clinical trial NCT06752668 · RECRUITING
Trial details
- NCT number
- NCT06752668
- Sponsor
- Centessa Pharmaceuticals (UK) Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-23
- Primary completion
- 2026-12-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.